Village Farms International (VFF) 10-Q 7 Nov 24 2024 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Sep. 30, 2024	Nov. 07, 2024
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Trading Symbol	VFF
Entity Registrant Name	VILLAGE FARMS INTERNATIONAL, INC.
Entity Central Index Key	0001584549
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Shell Company	false
Entity Small Business	true
Entity Emerging Growth Company	false
Security Exchange Name	NASDAQ
Title of 12(b) Security	Common Shares, without par value
Entity File Number	001-38783
Entity Incorporation State Country Code	A6
Entity Tax Identification Number	98-1007671
Entity Address, State or Province	FL
Entity Address, Address Line One	90 Colonial Parkway
Entity Address, City or Town	Lake Mary
Entity Address, Postal Zip Code	32746
City Area Code	407
Local Phone Number	936-1190
Document Quarterly Report	true
Document Transition Report	false
Entity Common Stock, Shares Outstanding		112,337,049

Condensed Consolidated Statemen

Condensed Consolidated Statements of Financial Position - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 28,696	$ 30,291
Restricted cash		5,000
Trade receivables	33,185	30,561
Inventories	60,022	78,472
Income tax receivable	8
Other receivables	937	294
Prepaid expenses and deposits	5,218	7,150
Total current assets	128,066	151,768
Non-current assets
Property, plant and equipment	200,271	205,613
Investments	2,656	2,656
Goodwill	44,996	55,918
Intangibles	27,494	32,275
Deferred tax asset	1,201	1,201
Right-of-use assets	10,978	12,596
Other assets	2,186	1,962
Total assets	417,848	463,989
Current liabilities
Line of credit	4,000	4,000
Trade payables	18,428	21,753
Current maturities of long-term debt	8,649	9,133
Accrued sales taxes	13,334	15,941
Accrued loyalty program	1,624	1,773
Accrued liabilities	12,407	15,076
Lease liabilities - current	2,489	2,112
Income tax payable		28
Other current liabilities	1,694	2,340
Total current liabilities	62,625	72,156
Non-current liabilities
Long-term debt	34,604	38,925
Deferred tax liability	23,954	23,730
Lease liabilities - non-current	9,453	11,335
Other liabilities	2,254	1,902
Total liabilities	132,890	148,048
MEZZANINE EQUITY
Redeemable non-controlling interest	10,608	15,667
SHAREHOLDERS’ EQUITY
Common stock, no par value per share - unlimited shares authorized; 112,337,049 shares issued and outstanding at September 30, 2024 and 110,248,929 shares issued and outstanding at December 31, 2023.	387,349	386,719
Additional paid in capital	30,338	25,611
Accumulated other comprehensive loss	(6,951)	(3,540)
Retained earnings	(136,386)	(109,165)
Total Village Farms International, Inc. shareholders' equity	274,350	299,625
Non-controlling interest	0	649
Total shareholders' equity	274,350	300,274
Total liabilities, mezzanine equity and shareholders’ equity	$ 417,848	$ 463,989

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Financial Position (Parenthetical) - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Assets [Abstract]
Common stock, no par value	$ 0	$ 0
Common stock, unlimited shares, authorized	Unlimited	Unlimited
Common stock, shares, issued	112,337,049	110,248,929
Common stock, shares, outstanding	112,337,049	110,248,929

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Statement [Abstract]
Sales	$ 83,368	$ 69,510	$ 253,627	$ 211,378
Cost of sales	(67,660)	(54,889)	(213,158)	(172,958)
Gross profit	15,708	14,621	40,469	38,420
Selling, general and administrative expenses	(16,540)	(15,822)	(52,593)	(49,980)
Interest expense	(784)	(988)	(2,606)	(3,532)
Interest income	229	262	757	741
Foreign exchange gain (loss)	352	(971)	(929)	(302)
Other income (loss)	379	(19)	528	5,613
Goodwill and intangible asset impairments			(11,939)
Loss before taxes	(656)	(2,917)	(26,313)	(9,040)
(Provision for) recovery of income taxes	(94)	1,664	(674)	(269)
Loss including non-controlling interests	(750)	(1,253)	(26,987)	(9,309)
Less: net income attributable to non-controlling interests, net of tax	(70)	(46)	(234)	(6)
Net loss attributable to Village Farms International, Inc. shareholders	$ (820)	$ (1,299)	$ (27,221)	$ (9,315)
Basic loss per share attributable to Village Farms International, Inc. shareholders	$ (0.01)	$ (0.01)	$ (0.25)	$ (0.09)
Diluted loss per share attributable to Village Farms International, Inc. shareholders	$ (0.01)	$ (0.01)	$ (0.25)	$ (0.09)
Weighted average number of common shares used in the computation of net loss per share (in thousands):
Basic	111,917	110,239	111,045	108,214
Diluted	111,917	110,239	111,045	108,214
Loss including non-controlling interests	$ (750)	$ (1,253)	$ (26,987)	$ (9,309)
Other comprehensive income (loss) :
Foreign currency translation adjustment	2,595	(5,986)	(3,655)	(899)
Comprehensive gain (loss) including non-controlling interests	1,845	(7,239)	(30,642)	(10,208)
Comprehensive (income) loss attributable to non-controlling interests	(222)	353	10	(50)
Comprehensive gain (loss) attributable to Village Farms International, Inc. shareholders	$ 1,623	$ (6,886)	$ (30,632)	$ (10,258)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Changes in Shareholders' Equity and Mezzanine Equity - USD ($) shares in Thousands, $ in Thousands	Total	Previously reported	Adjusments	Common Stock [Member]	Common Stock [Member] Previously reported	Additional Paid-in Capital [Member]	Additional Paid-in Capital [Member] Previously reported	Accumulated Other Comprehensive (Loss) Income [Member]	Accumulated Other Comprehensive (Loss) Income [Member] Previously reported	Retained Earnings [Member]	Retained Earnings [Member] Previously reported	Retained Earnings [Member] Adjusments	Noncontrolling Interest [Member]	Noncontrolling Interest [Member] Previously reported
Beginning Balance at Dec. 31, 2022	$ 303,830			$ 372,429		$ 13,372		$ (8,371)		$ (74,367)			$ 767
Beggining Balance (in shares) at Dec. 31, 2022				91,789
Mezzanine Equity, Beginning balance at Dec. 31, 2022	16,164
Proceeds from issuance of common stock / Shares issued in public offering, net of issuance costs	14,207			$ 14,207
Shares issued in pubic offering, net of issuance costs (in shares)				18,350
Warrants issued in public offering	9,128					9,128
Shares issued on exercise of stock options	83			$ 83
Shares issued on exercise of stock options (in shares)				100
Share-based compensation	3,135					3,135
Cumulative translation adjustment	213							184					29
Net (loss) Income	(9,495)									(9,315)			(180)
Mezanine Equity, Cumulative translation adjustment	(1,111)
Mezzanine Equity, Net (loss) income	185
Ending Balance at Sep. 30, 2023	321,101			$ 386,719		25,635		(8,187)		(83,682)			616
Ending Balance (in shares) at Sep. 30, 2023				110,239
Mezzanine Equity, Ending balance at Sep. 30, 2023	15,238
Beginning Balance at Jun. 30, 2023	326,608			$ 386,719		24,888		(3,284)		(82,383)			668
Beggining Balance (in shares) at Jun. 30, 2023				110,239
Mezzanine Equity, Beginning balance at Jun. 30, 2023	16,223
Share-based compensation	747					747
Cumulative translation adjustment	(4,874)							(4,903)					29
Net (loss) Income	(1,380)									(1,299)			(81)
Mezanine Equity, Cumulative translation adjustment	(1,111)
Mezzanine Equity, Net (loss) income	126
Ending Balance at Sep. 30, 2023	321,101			$ 386,719		25,635		(8,187)		(83,682)			616
Ending Balance (in shares) at Sep. 30, 2023				110,239
Mezzanine Equity, Ending balance at Sep. 30, 2023	15,238
Beginning Balance at Dec. 31, 2023	300,274	$ 303,274	$ (3,000)	$ 386,719	$ 386,719	25,611	$ 25,611	(3,540)	$ (3,540)	(109,165)	$ (106,165)	$ (3,000)	649	$ 649
Beggining Balance (in shares) at Dec. 31, 2023				110,249	110,249
Mezzanine Equity, Beginning balance at Dec. 31, 2023	15,667	15,667
Share-based compensation (in shares)				2,088
Share-based compensation	3,476			$ 630		2,846
Mezzanine Equity, Acquisition of redeemable non-controlling interests	(5,209)
Acquisition of Redeemable non-controlling interest	2,193					2,193
Acquisition of non-controlling interest	(801)					(312)							(489)
Cumulative translation adjustment	(3,411)							(3,411)
Net (loss) Income	(27,381)									(27,221)			(160)
Mezanine Equity, Cumulative translation adjustment	(244)
Mezzanine Equity, Net (loss) income	394
Ending Balance at Sep. 30, 2024	274,350			$ 387,349		30,338		(6,951)		(136,386)
Ending Balance (in shares) at Sep. 30, 2024				112,337
Mezzanine Equity, Ending balance at Sep. 30, 2024	10,608
Beginning Balance at Jun. 30, 2024	272,681	275,681	$ (3,000)	$ 386,719	$ 386,719	30,405	$ 30,405	(9,394)	$ (9,394)	(135,566)	$ (132,566)	$ (3,000)	517	$ 517
Beggining Balance (in shares) at Jun. 30, 2024				111,728	111,728
Mezzanine Equity, Beginning balance at Jun. 30, 2024	10,358	$ 10,358
Share-based compensation (in shares)				609
Share-based compensation	875			$ 630		245
Acquisition of non-controlling interest	(801)					(312)							(489)
Cumulative translation adjustment	2,470							2,443					27
Net (loss) Income	(875)									(820)			$ (55)
Mezanine Equity, Cumulative translation adjustment	125
Mezzanine Equity, Net (loss) income	125
Ending Balance at Sep. 30, 2024	274,350			$ 387,349		$ 30,338		$ (6,951)		$ (136,386)
Ending Balance (in shares) at Sep. 30, 2024				112,337
Mezzanine Equity, Ending balance at Sep. 30, 2024	$ 10,608

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Cash flows provided by (used in) operating activities:
Net loss attributable to Village Farms International, Inc. shareholders	$ (820)	$ (1,299)	$ (27,221)	$ (9,315)
Adjustments to reconcile net loss attributable to Village Farms International, Inc. shareholders to net cash provided by (used in) operating activities:
Depreciation and amortization			14,507	11,726
Amortization of deferred charges			10	102
Net income attributable to non-controlling interest	70	46	234	6
Interest expense	784	988	2,606	3,532
Interest paid on long-term debt			(3,128)	(3,645)
Unrealized foreign exchange loss			143	92
Goodwill and intangible asset impairments			11,939
Non-cash lease expense			1,684	1,615
Share-based compensation			3,476	3,135
Deferred income taxes			384	1,748
Changes in non-cash working capital items			5,302	(2,191)
Net cash provided by operating activities			9,936	6,805
Cash flows (used in) provided by investing activities:
Purchases of property, plant and equipment			(8,147)	(4,358)
Purchases of intangibles			(80)
Repayment of note receivable				835
Net cash used in investing activities			(8,227)	(3,523)
Cash flows (used in) provided by financing activities:
Repayments on borrowings			(4,301)	(7,858)
Purchase of Non-controlling interest			(3,817)
Proceeds from issuance of common stock and warrants				24,772
Issuance costs				(1,437)
Proceeds from exercise of stock options				83
Net cash (used in) provided by financing activities			(8,118)	15,560
Effect of exchange rate changes on cash and cash equivalents			(186)	(35)
Net (decrease) increase in cash, cash equivalents and restricted cash			(6,595)	18,807
Cash, cash equivalents and restricted cash, beginning of period			35,291	21,676	$ 21,676
Cash, cash equivalents and restricted cash, end of period	$ 28,696	$ 40,483	$ 28,696	$ 40,483	$ 35,291

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ (820)	$ (1,299)	$ (27,221)	$ (9,315)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Sep. 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Business, Basis Of Presentation

Business, Basis Of Presentation And Significant Accounting Policies	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Business, Basis Of Presentation And Significant Accounting Policies	1. BUSINESS, BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES Nature of Business Village Farms International, Inc. (“VFF” and, together with its subsidiaries, the “Company”, “we”, “us”, or “our”) is a corporation existing under the Business Corporations Act (Ontario). VFF’s principal operating subsidiaries as of September 30, 2024 were Village Farms Canada Limited Partnership, Village Farms, L.P.(together, “Village Farms Fresh” or “VF Fresh”), Pure Sunfarms Corp. (“Pure Sunfarms”), Balanced Health Botanicals, LLC (“Balanced Health”) and VF Clean Energy, Inc. ("VFCE") and Leli Holland B. V. ("Leli"). VFF also owns an 80 % interest in Rose LifeScience Inc. (“Rose”). The address of the registered office of VFF is 79 Wellington Street West, Suite 3300, Toronto, Ontario, Canada, M5K 1N2. The address of the principal executive office of VFF is 90 Colonial Center Pkwy, Lake Mary, Florida, United States, 32746. The Company’s shares are listed on Nasdaq Capital Market (“Nasdaq”) under the symbol “VFF”. Village Farms Fresh owns and operates sophisticated, highly intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells premium-quality tomatoes, bell peppers and cucumbers. Its wholly owned subsidiary, Pure Sunfarms, is a vertically integrated Licensed Producer and supplier of cannabis products sold to customers throughout Canada and internationally. The Company’s wholly owned subsidiary, Balanced Health, develops and sells high-quality, cannabidiol (“CBD”) based products including ingestible, edible and topical applications within the U.S. Through its 80 % ownership of Rose, the Company has a substantial presence in the Province of Quebec as a cannabis supplier, producer and commercialization expert. Basis of Presentation The accompanying condensed consolidated financial statements are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and with the instructions for Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and footnote disclosures normally included in the annual audited consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. The accompanying condensed consolidated statement of financial position as of December 31, 2023 is derived from the Company’s audited financial statements as of that date. Because certain information and footnote disclosures have been condensed or omitted, these condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto as of and for the year ended December 31, 2023 contained in the Company’s 2023 Annual Report on Form 10-K. In management’s opinion, all normal and recurring adjustments considered necessary for a fair presentation of the financial position, results of operations, and cash flows for the periods presented have been included. When necessary, certain prior year amounts have been reclassified to conform with the current period presentation. Interim period operating results do not necessarily indicate the results that may be expected for any other interim period or for the full fiscal year. The Company believes that the disclosures made in these condensed consolidated financial statements are adequate to make the information not misleading. Principals of Consolidation The accompanying condensed consolidated financial statements include Village Farms International, Inc. and its subsidiaries and include the accounts of all majority-owned subsidiaries over which the Company exercises control and, when applicable, entities in which the Company has a controlling financial interest. All significant intercompany balances and transactions have been eliminated in consolidation. Other parties’ interests in entities that the Company consolidates are reported as non-controlling interests within equity, except for mandatorily redeemable non-controlling interests, which are recorded within mezzanine equity. Net income or loss attributable to non-controlling interests is reported as a separate line item below net income or loss. The Company applies the equity method of accounting for its investments in entities for which it does not have a controlling financial interest, but over which it has the ability to exert significant influence. For equity investees in which the Company has an undivided interest in the assets, liabilities and profits or losses of an unconsolidated entity, but does not exercise control over the entity, the Company consolidates its proportional interest in the accounts of the entity. Translations of Foreign Currencies The assets and liabilities of foreign subsidiaries with a functional currency other than the U.S. dollar are translated into U.S. dollars at period-end exchange rates, with resulting translation gains or losses included within other comprehensive income or loss. Revenue and expenses are translated into U.S. dollars at average rates of exchange during the applicable period. Substantially all of the Company’s foreign operations use their local currency as their functional currency. For foreign operations for which the local currency is not the functional currency, the operation’s non-monetary assets are remeasured into U.S. dollars at historical exchange rates. All other accounts are remeasured at current exchange rates, with both gains or losses from remeasurement and currency gains or losses from transactions executed in currencies other than the functional currency included in foreign exchange (loss) gain. In these condensed consolidated financial statements, “$” means U.S. dollars and "C$" means Canadians dollars, unless otherwise noted. Revision of Prior-Period Consolidated Financial Statements In connection with the preparation of our third quarter 2024 condensed consolidated interim financial statements, the Company identified an immaterial misstatement in its estimate of its deferred tax asset valuation allowance as of the year ended December 31, 2023. As a result, we recorded a decrease to deferred tax assets as of December 31, 2023 and increase in income tax expense for the year ended December 31, 2023 for $ 3,000 , which decreased total assets and retained earnings as of December 31, 2023 and increased our net loss for the year ended December 31, 2023 by $ 3,000 . Our revision had no impact to the Company’s consolidated statement of cash flows. Additionally, our revision had no impact to the Company’s segment profit measure, compliance with debt covenants, or performance metrics used in the calculation of executive compensation as the impacted line items are excluded from these calculations. We evaluated the materiality of the impact quantitatively and qualitatively and concluded it was not material to any of the prior periods. General Economic, Regulatory and Market Conditions The Company has experienced, and may continue to experience, direct and indirect negative effects on its business and operations from negative economic, regulatory and market conditions, including inflationary effects on fuel prices, labor and materials costs, elevated interest rates, potential recessionary impacts and supply chain disruptions that could negatively affect demand for new projects and/or delay existing project timing or cause increased project costs. The extent to which general economic, regulatory and market conditions could affect the Company’s business, operations and financial results is uncertain as it will depend upon numerous evolving factors that management may not be able to accurately predict, and, therefore, any future impacts on the Company’s business, financial condition and/or results of operations cannot be quantified or predicted with specificity. Recent Accounting Pronouncements No accounting pronouncements recently issued or newly effective have had, or are expected to have, a material impact on the Company’s condensed consolidated financial statements.

Inventories

Inventories	9 Months Ended
	Sep. 30, 2024
Inventory Disclosure [Abstract]
Inventories	2. INVENTORIES Inventories consisted of the following as of: Classification September 30, 2024 December 31, 2023 Cannabis: Raw materials $ 668 $ 985 Work-in-progress 8,010 6,543 Finished goods 32,055 47,084 Packaging 7,175 7,641 Produce: Crop inventory 11,081 15,492 Purchased produce inventory 1,033 727 Inventory $ 60,022 $ 78,472

Property Plant And Equipment

Property Plant And Equipment	9 Months Ended
	Sep. 30, 2024
Property, Plant and Equipment [Abstract]
Property Plant And Equipment	3. PROPERTY, PLANT AND EQUIPMENT Property, plant and equipment consisted of the following as of: Classification September 30, 2024 December 31, 2023 Land $ 14,411 $ 14,641 Leasehold and land improvements 5,515 5,525 Buildings 215,140 217,384 Machinery and equipment 92,057 86,674 Construction in progress 15,370 13,619 Less: Accumulated depreciation ( 142,222 ) ( 132,230 ) Property, plant and equipment, net $ 200,271 $ 205,613 Depreciation expense on property, plant and equipment, was $ 4,360 and $ 12,108 for the three and nine months ended September 30, 2024, respectively, and $ 3,208 and $ 9,365 for the three and nine months ended September 30, 2023, respectively. Capitalized interest was $ 260 and $ 825 for the three and nine months ended September 30, 2024 , respectively, and $ 323 and $ 965 for the three and nine months ended September 30, 2023, respectively .

Acquisitions

Acquisitions	9 Months Ended
	Sep. 30, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Acquisitions	4. ACQUISITIONS On September 24, 2024 , the Company acquired the remaining 15 % equity ownership interest in Leli for a total cash purchase price of approximately $ 801 , which resulted in a reduction of non-controlling interest of ($ 489 ) and a decrease in additional paid in capital of ($ 312 ). The Company's ownership interest in Leli is now 100 %. On May 29, 2024 , the Company entered into a Share Purchase Agreement with Rose and non-controlling shareholders for the acquisition of an additional 10 % interest in Rose for a total cash purchase price of approximately $ 3,016 , which resulted in a reduction of mezzanine equity of ($ 5,209 ) and an increase in additional paid in capital of $ 2,193 . The Company's ownership interest in Rose is now 80 %.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	9 Months Ended
	Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	5. GOODWILL AND INTANGIBLE ASSETS Goodwill The following table presents the changes in the carrying value of goodwill by reportable segment for the nine months ended September 30, 2024: Cannabis - Canada Cannabis - United States Total Balance as of January 1, 2024 $ 45,879 $ 10,039 $ 55,918 Impairments - ( 10,039 ) ( 10,039 ) Foreign currency translation adjustment ( 883 ) - ( 883 ) Balance as of September 30, 2024 $ 44,996 $ - $ 44,996 Intangible Assets Intangible assets consisted of the following as of: Classification September 30, 2024 December 31, 2023 Licenses $ 18,351 $ 18,540 Brand and trademarks* 12,727 12,795 Customer relationships 13,324 13,586 Computer software 2,037 1,974 Other* 144 144 Less: Accumulated amortization ( 9,840 ) ( 7,414 ) Less: Impairments* ( 9,249 ) ( 7,350 ) Intangibles, net $ 27,494 $ 32,275 * Includes indefinite-lived intangible assets The expected future amortization expense for definite-lived intangible assets as of September 30, 2024 was as follows: Fiscal period Remainder of 2024 $ 838 2025 3,267 2026 3,178 2027 3,178 2028 1,884 Thereafter 11,527 Intangibles, net $ 23,872 Assessment for Indicators of Impairment At the end of each reporting period, the Company assesses whether events or changes in circumstances have occurred that would indicate an impairment. The Company considers external and internal factors, including overall financial performance and relevant entity-specific factors, as part of this assessment. During the nine months ended September 30, 2024 and 2023, the Company considered qualitative factors in assessing for impairment indicators for the Company’s U.S. and Canadian Cannabis segments. Cannabis - U.S. At June 30, 2024, when the Company considered qualitative factors in assessing impairment indicators, it concluded that the Company's U.S. - Cannabis segment more likely than not was impaired. The Company reviewed the reportable segment's assets, including goodwill and intangible assets. Based on recent historical performance during the quarter which underperformed relative to budget, a revised June 30, 2024 forecast which resulted in a shortfall compared to the March 31, 2024 forecast, the new restrictions on CBD sales in an additional eight states at July 1, 2024, and the proliferation of unregulated hemp-derived products on the market which continues to challenge market share for the CBD industry, the Company concluded that as of June 30, 2024, the fair value of the brand intangible asset and goodwill was fully impaired and an impairment charge to goodwill of $ 10,039 and a charge to intangibles of $ 1,900 was allocated to the U.S. Cannabis reporting unit. Cannabis - U.S. - Goodwill The fair value of the reporting unit was determined based on a discounted cash flow projection using projections for the remainder of 2024 to 2028 with an average revenue growth rate of 6 % between 2025 to 2028 , followed by a terminal growth rate of 2 %. Management concluded that as of June 30, 2024, the fair value was lower than its carrying amount and as a result, an impairment charge to goodwill of $ 10,039 was recorded to the reporting unit. The significant assumptions applied to the determination of the fair value are described below: Post-tax discount rate: A market participant post-tax discount rate applied to the after-tax forecast cash flows was 12 %. A decrease of 1 % to the discount rate, would not result in a material change to the impairment charge. Terminal growth rate: An increase of 1 % in the terminal growth rate would not result in a material change to the impairment charge. Future cash flows: An increase in future cash flows by 10 % would not result in a material change to the impairment charge. Cannabis – U.S. Brand The fair value of the brand was determined based on a discounted cash flow projection. Specifically, the Company utilized a relief from royalty valuation technique to arrive at the fair value of the brand. Management concluded that as of June 30, 2024, the fair value was lower than its carrying value of $ 1,900 as the notional brand maintenance costs exceeded the incremental royalty of 3.5 %. Therefore, an impairment charge to the brand intangible of $ 1,900 was allocated to the reporting unit. Cannabis - Canada At September 30, 2024, when the Company considered qualitative factors in assessing impairment indicators for Canadian Cannabis, it concluded that no impairment indicators existed as no events or circumstances occurred that would, more likely than not, reduce the fair value of the reporting units to be below their carrying amounts. At September 30, 2023 , the Company concluded that no impairment indicators existed as no events or circumstances occurred that would, more likely than not, reduce the fair value of the reporting units to be below their carrying amounts.

Line of Credit and Long-term De

Line of Credit and Long-term Debt	9 Months Ended
	Sep. 30, 2024
Debt Disclosure [Abstract]
Line of Credit and Long-term Debt	6. LINE OF CREDIT AND LONG-TERM DEBT The following table provides details for the carrying values of debt as of: September 30, 2024 December 31, 2023 Term Loan - ("FCC Loan") - repayable by monthly principal payments of $ 164 and accrued interest at a rate of 8.81 %; matures May 3, 2027 $ 21,312 $ 22,788 Term Loan - Pure Sunfarms - C$ 19.0 M - Canadian prime interest rate plus an applicable margin, repayable in quarterly payments equal to 2.50 % of the outstanding principal amount, interest rate of 8.45 %; matures February 7, 2026 7,028 8,298 Term loan - Pure Sunfarms - C$ 25.0 M - Canadian prime interest rate plus an applicable margin, repayable in quarterly payments equal to 2.50 % of the outstanding principal amount, interest rate of 8.45 %; matures February 7, 2026 11,560 13,201 BDC Facility - Pure Sunfarms - non-revolving demand loan repayable by monthly principal payments of C$ 52 and accrued interest at a rate of 10.20 %, matures December 31, 2031 3,353 3,771 Total $ 43,253 $ 48,058 The Company’s line of credit with Bank of Montreal ("Operating Loan") had $ 4,000 drawn on the facility as of September 30, 2024 and December 31, 2023. The carrying value of the assets and securities pledged as collateral for the FCC Loan as of September 30, 2024 and December 31, 2023 was $ 74,942 and $ 117,293 , respectively. The carrying value of the assets pledged as collateral for the Operating Loan as of September 30, 2024 and December 31, 2023 was $ 23,233 and $ 28,034 , respectively. The Pure Sunfarms line of credit had a balance of $ 0 as of September 30, 2024 and December 31, 2023. The Company is required to comply with financial covenants, measured either quarterly or annually depending on the covenant. The Company was in compliance with all its credit facility covenants as of September 30, 2024. The weighted average annual interest rate on short-term borrowings as of September 30, 2024 and December 31, 2023 was 9.21 % and 9.44 % , respectively. Accrued interest payable on all long-term debt as of September 30, 2024 and December 31, 2023 was $ 405 and $ 390 , respectively, and these amounts are included in accrued liabilities in the Condensed Consolidated Statements of Financial Position. The aggregate annual principal maturities of long-term debt for the remainder of 2024 and thereafter are as follows: Remainder of 2024 $ 1,440 2025 5,759 2026 16,856 2027 17,348 2028 462 Thereafter 1,388 Total $ 43,253

Financial Instruments

Financial Instruments	9 Months Ended
	Sep. 30, 2024
Investments, All Other Investments [Abstract]
Financial Instruments	7. FINANCIAL INSTRUMENTS The Company’s financial instruments include cash and cash equivalents, trade receivables, minority investments, line of credit, trade payables, accrued liabilities, lease liabilities, note payables and debt. The carrying value of cash and cash equivalents, trade receivables, trade payables, and accrued liabilities approximate their fair values due to the short-term maturity of these financial instruments. The carrying value of line of credit, lease liabilities, notes payable, and debt approximate their fair values due to insignificant changes in credit risk. Carrying amounts of other long-term financial instruments, excluding the Company's term loans, approximate fair value, since the instruments bear interest at variable or fixed rates which approximate market rates. For its investments, the Company has selected the practicability election to fair value measurement, under which the investment is measured at cost, less impairment, plus or minus observable price changes of an identical or similar investment.

Related Party Transactions And

Related Party Transactions And Balances	9 Months Ended
	Sep. 30, 2024
Related Party Transactions [Abstract]
Related Party Transaction And Balances	8. RELATED PARTY TRANSACTIONS AND BALANCES The Company leases its Rose office building from a Company employee who also owns a minority interest in Rose. For the three and nine months ended September 30, 2024, the Company paid C $ 40 and C $ 230 , respectively and for the three and nine months ended September 30, 2023 the Company paid C $ 80 and C $ 172 , respectively, to lease this office space. One of the Company’s employees is related to a member of the Company’s executive management team and received approximately $ 45 and $ 130 in salary and benefits during the three and nine months ended September 30, 2024, respectively, and $ 42 and $ 103 in salary and benefits during the three and nine months ended September 30, 2023, respectively. On May 29, 2024, the Company entered into a Share Purchase Agreement with Rose and non-controlling shareholders, which includes two company employees, for the acquisition of an additional 10 % interest in Rose for a total cash purchase price of approximately $ 3,016 (note 4).

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2024
Income Tax Disclosure [Abstract]
Income Taxes	9. INCOME TAXES The Company has recorded a provision for income taxes of ($ 94 ) and ($ 674 ) for the three and nine months ended September 30, 2024, respectively, compared with a recovery of (provision for) income taxes of $ 1,664 and ($ 269 ) for the same periods last year. The Company’s income tax provision is based on management’s estimate of the effective tax rate for the full year. The tax (provision) benefit in any period will be affected by, among other things, permanent, as well as discrete items, differences in the deductibility of certain items, changes in the valuation allowance related to net deferred tax assets, in addition to changes in tax legislation. As a result, the Company may experience significant fluctuations in the effective book tax rate (that is, tax expense divided by pre-tax book income) from period to period. In order to fully utilize the net deferred tax assets, the Company will need to generate sufficient taxable income in future years. The Company analyzed all positive and negative evidence to determine if, based on the weight of available evidence, it is more likely than not to realize the benefit of the net deferred tax assets. The recognition of the net deferred tax assets and related tax benefits is based upon the Company’s conclusions regarding, among other considerations, estimates of future earnings based on information currently available and current and anticipated customers, contracts, and product introductions, as well as historical operating results and certain tax planning strategies. Based on the analysis of all available evidence, both positive and negative, the Company has concluded that it does not have the ability to generate sufficient taxable income in the necessary periods to utilize the entire benefit for its deferred tax assets. Accordingly, the Company established a valuati on allowance of $ 48,742 as of September 30, 2024 and $ 42,530 as of December 31, 2023. The Company cannot presently estimate what, if any, changes to the valuation of its deferred tax assets may be deemed appropriate in the future. As of September 30, 2024, the Company’s net deferred tax assets totaled $ 1,201 a nd were primarily derived from a tax planning strategy to utilize a portion of its existing net operating loss carryforwards.

Segment and Geographic Informat

Segment and Geographic Information	9 Months Ended
	Sep. 30, 2024
Segment Reporting [Abstract]
Segment and Geographic Information	10. SEGMENT AND GEOGRAPHIC INFORMATION Segment reporting is prepared on the same basis that the Company’s Chief Executive Officer, who is the Company’s Chief Operating Decision Maker, assesses performance and allocates resources. As of September 30, 2024 , the Company’s four segments are as follows: Segment Description Produce The Produce segment produces, markets, and sells premium quality tomatoes, bell peppers and cucumbers. Cannabis – Canada The Cannabis – Canada segment produces and supplies cannabis products to be sold to other licensed providers and provincial governments across Canada and internationally. Cannabis – United States The Cannabis – United States segment develops and sells high-quality, CBD-based health and wellness products including ingestible, edible and topical applications. Energy The Energy business receives a royalty from a renewable natural gas facility that is located in Delta, B.C. The Company’s primary operations are in the United States and Canada. Segment information is summarized below: Three months ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Sales Produce $ 42,770 $ 35,712 $ 125,883 $ 114,125 Cannabis - Canada 36,463 28,810 114,654 81,987 Cannabis - United States 3,943 4,988 12,777 15,266 Energy 192 — 313 — $ 83,368 $ 69,510 $ 253,627 $ 211,378 Gross profit Produce $ 3,481 $ 1,492 $ 2,627 $ ( 654 ) Cannabis - Canada 9,599 9,944 29,812 29,114 Cannabis - United States 2,500 3,185 7,824 9,981 Energy 128 — 206 ( 21 ) $ 15,708 $ 14,621 $ 40,469 $ 38,420 Income (loss) before taxes Produce $ 403 $ ( 1,172 ) $ ( 7,787 ) $ ( 4,497 ) Cannabis - Canada 1,600 1,918 4,689 5,003 Cannabis - United States ( 192 ) 79 ( 13,173 ) ( 125 ) Energy 297 ( 58 ) 338 ( 128 ) $ 2,108 $ 767 $ ( 15,933 ) $ 253 A reconciliation of the Company’s segment Income (loss) before taxes to the Condensed Consolidated Statements of Operations is summarized below: Three months ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Segment operating income $ 2,108 $ 767 $ ( 15,933 ) $ 253 Other corporate expenses, net ( 2,764 ) ( 3,684 ) ( 10,380 ) ( 9,293 ) Total income (loss) before taxes $ ( 656 ) $ ( 2,917 ) $ ( 26,313 ) $ ( 9,040 )

Loss Per Share

Loss Per Share	9 Months Ended
	Sep. 30, 2024
Earnings Per Share [Abstract]
Loss Per Share	11. LOSS PER SHARE Basic and diluted net loss per common share is calculated as follows: Three months ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Numerator: Net loss attributable to Village Farms International, Inc. shareholders $ ( 820 ) $ ( 1,299 ) $ ( 27,221 ) $ ( 9,315 ) Denominator: Weighted average number of common shares - basic 111,917 110,239 111,045 108,214 Effect of dilutive securities- share-based employee options and awards — — — — Weighted average number of common shares - diluted 111,917 110,239 111,045 108,214 Antidilutive options and awards 6,692 6,509 6,692 6,509 Net loss per ordinary share: Basic $ ( 0.01 ) $ ( 0.01 ) $ ( 0.25 ) $ ( 0.09 ) Diluted $ ( 0.01 ) $ ( 0.01 ) $ ( 0.25 ) $ ( 0.09 )

Shareholders' Equity and Share

Shareholders' Equity and Share Based Compensation	9 Months Ended
	Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]
Shareholders' Equity and Share Based Compensation	12. SHAREHOLDERS’ EQUITY AND SHARE-BASED COMPENSATION Share-based compensation expense was $ 875 and $ 3,476 for the three and nine months ended September 30, 2024, respectively, and $ 747 and $ 3,135 for the three and nine months ended September 30, 2023, respectively. Stock option activity for the nine months ended September 30, 2024 was as follows: Number of Weighted Weighted Aggregate Outstanding at January 1, 2024 6,946,576 $ 3.50 7.54 $ 83 Granted 170,000 $ 0.95 6.21 $ 5 Forfeited/expired ( 424,167 ) $ 3.43 Outstanding at September 30, 2024 6,692,409 $ 3.43 7.09 $ 294 Exercisable at September 30, 2024 3,600,055 $ 5.24 5.97 $ 57 Restricted shares activity for the nine months ended September 30, 2024 was as follows: Number of Weighted Average Grant Date Fair Value Outstanding at January 1, 2024 — $ - Granted 1,785,144 $ 1.20 Vested and Issued ( 1,479,024 ) $ 1.25 Outstanding at September 30, 2024 306,120 $ 0.98 Exercisable at September 30, 2024 — $ - On September 3, 2024, the Company granted 600,000 shares to a director of the Company.

Changes in Non Cash Working Cap

Changes in Non Cash Working Capital Items and Supplemental Cash Flow Information	9 Months Ended
	Sep. 30, 2024
Disclosure Of Changes In Non Cash Working Capital Items And Supplemental Cash Flow Information [Abstract]
Changes in Non Cash Working Capital Items and Supplemental Cash Flow Information	13. CHANGES IN NON-CASH WORKING CAPITAL ITEMS AND SUPPLEMENTAL CASH FLOW INFORMATION Nine Months Ended September 30, 2024 2023 Trade receivables $ ( 625 ) $ ( 475 ) Inventories 16,000 ( 5,284 ) Other receivables ( 65 ) 9 Prepaid expenses and deposits 1,774 ( 845 ) Trade payables ( 3,231 ) ( 3,624 ) Accrued liabilities ( 3,136 ) 5,383 Lease liabilities ( 1,617 ) ( 1,574 ) Other assets, net of other liabilities ( 3,798 ) 4,219 $ 5,302 $ ( 2,191 ) The Company paid income taxes of $ 0 for the three and nine months ended September 30, 2024 and 2023. The Company paid interest expense of $ 955 and $ 3,128 for the three and nine months ended September 30, 2024 , respectively, and $ 1,008 and $ 3,645 for the three and nine months ended September 30, 2023 , respectively.

Business, Basis Of Presentati_2

Business, Basis Of Presentation And Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying condensed consolidated financial statements are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and with the instructions for Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and footnote disclosures normally included in the annual audited consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. The accompanying condensed consolidated statement of financial position as of December 31, 2023 is derived from the Company’s audited financial statements as of that date. Because certain information and footnote disclosures have been condensed or omitted, these condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto as of and for the year ended December 31, 2023 contained in the Company’s 2023 Annual Report on Form 10-K. In management’s opinion, all normal and recurring adjustments considered necessary for a fair presentation of the financial position, results of operations, and cash flows for the periods presented have been included. When necessary, certain prior year amounts have been reclassified to conform with the current period presentation. Interim period operating results do not necessarily indicate the results that may be expected for any other interim period or for the full fiscal year. The Company believes that the disclosures made in these condensed consolidated financial statements are adequate to make the information not misleading.
Principals of Consolidation	Principals of Consolidation The accompanying condensed consolidated financial statements include Village Farms International, Inc. and its subsidiaries and include the accounts of all majority-owned subsidiaries over which the Company exercises control and, when applicable, entities in which the Company has a controlling financial interest. All significant intercompany balances and transactions have been eliminated in consolidation. Other parties’ interests in entities that the Company consolidates are reported as non-controlling interests within equity, except for mandatorily redeemable non-controlling interests, which are recorded within mezzanine equity. Net income or loss attributable to non-controlling interests is reported as a separate line item below net income or loss. The Company applies the equity method of accounting for its investments in entities for which it does not have a controlling financial interest, but over which it has the ability to exert significant influence. For equity investees in which the Company has an undivided interest in the assets, liabilities and profits or losses of an unconsolidated entity, but does not exercise control over the entity, the Company consolidates its proportional interest in the accounts of the entity.
Translations of Foreign Currencies	Translations of Foreign Currencies The assets and liabilities of foreign subsidiaries with a functional currency other than the U.S. dollar are translated into U.S. dollars at period-end exchange rates, with resulting translation gains or losses included within other comprehensive income or loss. Revenue and expenses are translated into U.S. dollars at average rates of exchange during the applicable period. Substantially all of the Company’s foreign operations use their local currency as their functional currency. For foreign operations for which the local currency is not the functional currency, the operation’s non-monetary assets are remeasured into U.S. dollars at historical exchange rates. All other accounts are remeasured at current exchange rates, with both gains or losses from remeasurement and currency gains or losses from transactions executed in currencies other than the functional currency included in foreign exchange (loss) gain. In these condensed consolidated financial statements, “$” means U.S. dollars and "C$" means Canadians dollars, unless otherwise noted.
Revision of Prior-Period Consolidated Financial Statements	Revision of Prior-Period Consolidated Financial Statements In connection with the preparation of our third quarter 2024 condensed consolidated interim financial statements, the Company identified an immaterial misstatement in its estimate of its deferred tax asset valuation allowance as of the year ended December 31, 2023. As a result, we recorded a decrease to deferred tax assets as of December 31, 2023 and increase in income tax expense for the year ended December 31, 2023 for $ 3,000 , which decreased total assets and retained earnings as of December 31, 2023 and increased our net loss for the year ended December 31, 2023 by $ 3,000 . Our revision had no impact to the Company’s consolidated statement of cash flows. Additionally, our revision had no impact to the Company’s segment profit measure, compliance with debt covenants, or performance metrics used in the calculation of executive compensation as the impacted line items are excluded from these calculations. We evaluated the materiality of the impact quantitatively and qualitatively and concluded it was not material to any of the prior periods.
General Economic, Regulatory and Market Conditions	General Economic, Regulatory and Market Conditions The Company has experienced, and may continue to experience, direct and indirect negative effects on its business and operations from negative economic, regulatory and market conditions, including inflationary effects on fuel prices, labor and materials costs, elevated interest rates, potential recessionary impacts and supply chain disruptions that could negatively affect demand for new projects and/or delay existing project timing or cause increased project costs. The extent to which general economic, regulatory and market conditions could affect the Company’s business, operations and financial results is uncertain as it will depend upon numerous evolving factors that management may not be able to accurately predict, and, therefore, any future impacts on the Company’s business, financial condition and/or results of operations cannot be quantified or predicted with specificity.
Recent Accounting Pronouncements	Recent Accounting Pronouncements No accounting pronouncements recently issued or newly effective have had, or are expected to have, a material impact on the Company’s condensed consolidated financial statements.

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Sep. 30, 2024
Inventory Disclosure [Abstract]
Schedule of Inventory, Current	Inventories consisted of the following as of: Classification September 30, 2024 December 31, 2023 Cannabis: Raw materials $ 668 $ 985 Work-in-progress 8,010 6,543 Finished goods 32,055 47,084 Packaging 7,175 7,641 Produce: Crop inventory 11,081 15,492 Purchased produce inventory 1,033 727 Inventory $ 60,022 $ 78,472

Property Plant And Equipment (T

Property Plant And Equipment (Tables)	9 Months Ended
	Sep. 30, 2024
Property, Plant and Equipment [Abstract]
Summary of Property, Plant and Equipment	Property, plant and equipment consisted of the following as of: Classification September 30, 2024 December 31, 2023 Land $ 14,411 $ 14,641 Leasehold and land improvements 5,515 5,525 Buildings 215,140 217,384 Machinery and equipment 92,057 86,674 Construction in progress 15,370 13,619 Less: Accumulated depreciation ( 142,222 ) ( 132,230 ) Property, plant and equipment, net $ 200,271 $ 205,613

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Changes in Carrying Value of Goodwill by Reportable Segment	The following table presents the changes in the carrying value of goodwill by reportable segment for the nine months ended September 30, 2024: Cannabis - Canada Cannabis - United States Total Balance as of January 1, 2024 $ 45,879 $ 10,039 $ 55,918 Impairments - ( 10,039 ) ( 10,039 ) Foreign currency translation adjustment ( 883 ) - ( 883 ) Balance as of September 30, 2024 $ 44,996 $ - $ 44,996
Schedule of Acquired Intangible Assets	Intangible assets consisted of the following as of: Classification September 30, 2024 December 31, 2023 Licenses $ 18,351 $ 18,540 Brand and trademarks* 12,727 12,795 Customer relationships 13,324 13,586 Computer software 2,037 1,974 Other* 144 144 Less: Accumulated amortization ( 9,840 ) ( 7,414 ) Less: Impairments* ( 9,249 ) ( 7,350 ) Intangibles, net $ 27,494 $ 32,275 * Includes indefinite-lived intangible assets
Schedule of Expected Future Amortization Expense for Definite-Lived Intangible Assets	The expected future amortization expense for definite-lived intangible assets as of September 30, 2024 was as follows: Fiscal period Remainder of 2024 $ 838 2025 3,267 2026 3,178 2027 3,178 2028 1,884 Thereafter 11,527 Intangibles, net $ 23,872

Line of Credit and Long-term _2

Line of Credit and Long-term Debt (Tables)	9 Months Ended
	Sep. 30, 2024
Debt Disclosure [Abstract]
Schedule of Carrying Values of Debt	The following table provides details for the carrying values of debt as of: September 30, 2024 December 31, 2023 Term Loan - ("FCC Loan") - repayable by monthly principal payments of $ 164 and accrued interest at a rate of 8.81 %; matures May 3, 2027 $ 21,312 $ 22,788 Term Loan - Pure Sunfarms - C$ 19.0 M - Canadian prime interest rate plus an applicable margin, repayable in quarterly payments equal to 2.50 % of the outstanding principal amount, interest rate of 8.45 %; matures February 7, 2026 7,028 8,298 Term loan - Pure Sunfarms - C$ 25.0 M - Canadian prime interest rate plus an applicable margin, repayable in quarterly payments equal to 2.50 % of the outstanding principal amount, interest rate of 8.45 %; matures February 7, 2026 11,560 13,201 BDC Facility - Pure Sunfarms - non-revolving demand loan repayable by monthly principal payments of C$ 52 and accrued interest at a rate of 10.20 %, matures December 31, 2031 3,353 3,771 Total $ 43,253 $ 48,058
Schedule of principal maturities of long term debt	The aggregate annual principal maturities of long-term debt for the remainder of 2024 and thereafter are as follows: Remainder of 2024 $ 1,440 2025 5,759 2026 16,856 2027 17,348 2028 462 Thereafter 1,388 Total $ 43,253

Segment and Geographic Inform_2

Segment and Geographic Information (Tables)	9 Months Ended
	Sep. 30, 2024
Segment Reporting [Abstract]
Summary of Net Sales by the Countries and Business	The Company’s primary operations are in the United States and Canada. Segment information is summarized below: Three months ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Sales Produce $ 42,770 $ 35,712 $ 125,883 $ 114,125 Cannabis - Canada 36,463 28,810 114,654 81,987 Cannabis - United States 3,943 4,988 12,777 15,266 Energy 192 — 313 — $ 83,368 $ 69,510 $ 253,627 $ 211,378 Gross profit Produce $ 3,481 $ 1,492 $ 2,627 $ ( 654 ) Cannabis - Canada 9,599 9,944 29,812 29,114 Cannabis - United States 2,500 3,185 7,824 9,981 Energy 128 — 206 ( 21 ) $ 15,708 $ 14,621 $ 40,469 $ 38,420 Income (loss) before taxes Produce $ 403 $ ( 1,172 ) $ ( 7,787 ) $ ( 4,497 ) Cannabis - Canada 1,600 1,918 4,689 5,003 Cannabis - United States ( 192 ) 79 ( 13,173 ) ( 125 ) Energy 297 ( 58 ) 338 ( 128 ) $ 2,108 $ 767 $ ( 15,933 ) $ 253
Summary of Reconciliation of the Company's Segment Income (Loss) Before Taxes	A reconciliation of the Company’s segment Income (loss) before taxes to the Condensed Consolidated Statements of Operations is summarized below: Three months ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Segment operating income $ 2,108 $ 767 $ ( 15,933 ) $ 253 Other corporate expenses, net ( 2,764 ) ( 3,684 ) ( 10,380 ) ( 9,293 ) Total income (loss) before taxes $ ( 656 ) $ ( 2,917 ) $ ( 26,313 ) $ ( 9,040 )

Loss Per Share (Tables)

Loss Per Share (Tables)	9 Months Ended
	Sep. 30, 2024
Income Per Share [Abstract]
Summary of Basic and Diluted Net Loss per Common Share	Basic and diluted net loss per common share is calculated as follows: Three months ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Numerator: Net loss attributable to Village Farms International, Inc. shareholders $ ( 820 ) $ ( 1,299 ) $ ( 27,221 ) $ ( 9,315 ) Denominator: Weighted average number of common shares - basic 111,917 110,239 111,045 108,214 Effect of dilutive securities- share-based employee options and awards — — — — Weighted average number of common shares - diluted 111,917 110,239 111,045 108,214 Antidilutive options and awards 6,692 6,509 6,692 6,509 Net loss per ordinary share: Basic $ ( 0.01 ) $ ( 0.01 ) $ ( 0.25 ) $ ( 0.09 ) Diluted $ ( 0.01 ) $ ( 0.01 ) $ ( 0.25 ) $ ( 0.09 )

Shareholders' Equity and Shar_2

Shareholders' Equity and Share Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]
Summary of Stock Option Activity	Stock option activity for the nine months ended September 30, 2024 was as follows: Number of Weighted Weighted Aggregate Outstanding at January 1, 2024 6,946,576 $ 3.50 7.54 $ 83 Granted 170,000 $ 0.95 6.21 $ 5 Forfeited/expired ( 424,167 ) $ 3.43 Outstanding at September 30, 2024 6,692,409 $ 3.43 7.09 $ 294 Exercisable at September 30, 2024 3,600,055 $ 5.24 5.97 $ 57
Summary of Restricted Shares Activity	Restricted shares activity for the nine months ended September 30, 2024 was as follows: Number of Weighted Average Grant Date Fair Value Outstanding at January 1, 2024 — $ - Granted 1,785,144 $ 1.20 Vested and Issued ( 1,479,024 ) $ 1.25 Outstanding at September 30, 2024 306,120 $ 0.98 Exercisable at September 30, 2024 — $ -

Changes in Non Cash Working C_2

Changes in Non Cash Working Capital Items and Supplemental Cash Flow Information (Tables)	9 Months Ended
	Sep. 30, 2024
Disclosure Of Changes In Non Cash Working Capital Items And Supplemental Cash Flow Information [Abstract]
Summary of Changes in Non Cash Working Capital Items and Supplemental Cash Flow Information	Nine Months Ended September 30, 2024 2023 Trade receivables $ ( 625 ) $ ( 475 ) Inventories 16,000 ( 5,284 ) Other receivables ( 65 ) 9 Prepaid expenses and deposits 1,774 ( 845 ) Trade payables ( 3,231 ) ( 3,624 ) Accrued liabilities ( 3,136 ) 5,383 Lease liabilities ( 1,617 ) ( 1,574 ) Other assets, net of other liabilities ( 3,798 ) 4,219 $ 5,302 $ ( 2,191 )

Business, Basis Of Presentati_3

Business, Basis Of Presentation And Significant Accounting Policies - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Nature Of Operations [Line Items]
Deferred tax asset	$ 1,201		$ 1,201		$ 1,201
Income tax expense	94	$ (1,664)	674	$ 269
Retained earnings	(136,386)		(136,386)		(109,165)
Total assets	417,848		417,848		463,989
Net Income (Loss)	$ (820)	$ (1,299)	$ (27,221)	$ (9,315)
Restatement [Member]
Nature Of Operations [Line Items]
Deferred tax asset					(3,000)
Income tax expense					3,000
Retained earnings					(3,000)
Total assets					(3,000)
Net Income (Loss)					$ (3,000)
Rose LifeScience Inc. [Member]
Nature Of Operations [Line Items]
Equity ownership percentage	80%		80%

Inventories - Summary of Invent

Inventories - Summary of Inventory Current (Detail) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Inventory [Line Items]
Inventories	$ 60,022	$ 78,472
Raw Materials [Member] | Cannabis Business [Member]
Inventory [Line Items]
Inventories	668	985
Work-In-Progress [Member] | Cannabis Business [Member]
Inventory [Line Items]
Inventories	8,010	6,543
Finished Goods [Member] | Cannabis Business [Member]
Inventory [Line Items]
Inventories	32,055	47,084
Packaging [Member] | Cannabis Business [Member]
Inventory [Line Items]
Inventories	7,175	7,641
Crop Inventory [Member] | Produce And Energy
Inventory [Line Items]
Inventories	11,081	15,492
Purchased Produce Inventory [Member] | Produce And Energy
Inventory [Line Items]
Inventories	$ 1,033	$ 727

Property Plant And Equipment -

Property Plant And Equipment - Summary of Property, Plant and Equipment (Detail) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Property Plant And Equipment [Line Items]
Less: Accumulated depreciation	$ (142,222)	$ (132,230)
Property, plant and equipment, net	200,271	205,613
Land [Member]
Property Plant And Equipment [Line Items]
Property, Plant and Equipment, Gross	14,411	14,641
Leaseholds and Leasehold Improvements [Member]
Property Plant And Equipment [Line Items]
Property, Plant and Equipment, Gross	5,515	5,525
Buildings [Member]
Property Plant And Equipment [Line Items]
Property, Plant and Equipment, Gross	215,140	217,384
Machinery and Equipment [Member]
Property Plant And Equipment [Line Items]
Property, Plant and Equipment, Gross	92,057	86,674
Construction in Progress [Member]
Property Plant And Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 15,370	$ 13,619

Property Plant And Equipment _2

Property Plant And Equipment - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Property, Plant and Equipment [Abstract]
Depreciation on property, plant and equipment	$ 4,360	$ 3,208	$ 12,108	$ 9,365
Capitalized interest	$ 260	$ 323	$ 825	$ 965

Acquisitions - Additional Infor

Acquisitions - Additional Information (Detail) - USD ($) $ in Thousands			3 Months Ended	9 Months Ended
	Sep. 24, 2024	May 29, 2024	Sep. 30, 2024	Sep. 30, 2024
Business Acquisition [Line Items]
Mezzanine equity acquisition of non-controlling interests				$ (5,209)
Mezzanine equity increase in additional paid in capital				2,193
Decrease in additional paid in capital			$ (801)	(801)
Additional Paid-in Capital [Member]
Business Acquisition [Line Items]
Mezzanine equity increase in additional paid in capital				2,193
Decrease in additional paid in capital			$ (312)	$ (312)
Rose Acquisition [Member]
Business Acquisition [Line Items]
Date of acquisition agreement		May 29, 2024
Percentage of additional voting interests acquired		10%
Additional percentage of voting interests acquired			80%	80%
Cash purchase price		$ 3,016
Mezzanine equity acquisition of non-controlling interests		(5,209)
Rose Acquisition [Member] | Additional Paid-in Capital [Member]
Business Acquisition [Line Items]
Mezzanine equity increase in additional paid in capital		$ 2,193
Leli [Member]
Business Acquisition [Line Items]
Date of acquisition agreement	Sep. 24, 2024
Percentage of remaining voting interests acquired	15%
Additional percentage of voting interests acquired			100%	100%
Cash purchase price	$ 801
Reduction of non-controlling interest	(489)
Leli [Member] | Additional Paid-in Capital [Member]
Business Acquisition [Line Items]
Decrease in additional paid in capital	$ (312)

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Schedule of Changes in Carrying Value of Goodwill by Reportable Segment (Detail) $ in Thousands	9 Months Ended
	Sep. 30, 2024 USD ($)
Goodwill [Line Items]
Beginning Balance	$ 55,918
Impairments	(10,039)
Foreign currency translation adjustment	(883)
Ending Balance	44,996
Cannabis Business [Member] | Canada [Member]
Goodwill [Line Items]
Beginning Balance	45,879
Foreign currency translation adjustment	(883)
Ending Balance	44,996
Cannabis Business [Member] | United States [Member]
Goodwill [Line Items]
Beginning Balance	10,039
Impairments	$ (10,039)

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Schedule of Acquired Intangible Assets (Detail) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Finite Lived Intangible Assets [Line Items]
Less: Accumulated amortization	$ (9,840)	$ (7,414)
Less: Impairments	(9,249)	(7,350)
Intangibles, net	27,494	32,275
Licenses [Member]
Finite Lived Intangible Assets [Line Items]
Intangibles, gross	18,351	18,540
Brand and Trademarks [Member]
Finite Lived Intangible Assets [Line Items]
Intangibles, gross	12,727	12,795
Customer Relationships [Member]
Finite Lived Intangible Assets [Line Items]
Intangibles, gross	13,324	13,586
Computer Software [Member]
Finite Lived Intangible Assets [Line Items]
Intangibles, gross	2,037	1,974
Other [Member]
Finite Lived Intangible Assets [Line Items]
Intangibles, gross	$ 144	$ 144

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets - Schedule of Expected Future Amortization Expense for Definite-Lived Intangible Assets (Detail) $ in Thousands	Sep. 30, 2024 USD ($)
Fiscal period
Remainder of 2024	$ 838
2025	3,267
2026	3,178
2027	3,178
2028	1,884
Thereafter	11,527
Intangibles, net	$ 23,872

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets - Additional Information (Detail) - USD ($) $ in Thousands	6 Months Ended	9 Months Ended
	Jun. 30, 2024	Sep. 30, 2024	Dec. 31, 2023
Goodwill [Line Items]
Impairments		$ 10,039
Impairment charge to intangibles		9,249	$ 7,350
Good will		44,996	55,918
Intangible assets		$ (9,249)	$ (7,350)
Cannabis U.S. [Member]
Goodwill [Line Items]
Impairment charge to intangibles	$ 1,900
Good will	10,039
Intangible assets	(1,900)
Cannabis U.S. [Member] | Brand [Member]
Goodwill [Line Items]
Recovered amount higher (lower) than carrying amount of brand	$ 1,900
Incremental royalty rate	3.50%
Impairment charge to intangibles	$ 1,900
Intangible assets	(1,900)
Cannabis U.S. [Member] | Goodwill [Member]
Goodwill [Line Items]
Recovered amount higher (lower) than carrying amount of goodwill	$ 10,039
Post-tax discount rate	12%
Increase in post-tax discount rate	1%
Recoverable amount average revenue growth rate	6%
Recoverable amount terminal growth rate	2%
Decrease in terminal growth rate	1%
Decrease future cash flow rate	10%
Cannabis U.S. [Member] | Goodwill [Member] | Maximum [Member]
Goodwill [Line Items]
Ending period of recoverable amount budgets approved by senior management	2028
Recoverable amount average revenue growth rate period	2028
Cannabis U.S. [Member] | Goodwill [Member] | Minimum [Member]
Goodwill [Line Items]
Starting period of recoverable amount budgets approved by senior management	2024
Recoverable amount average revenue growth rate period	2025

Line of Credit and Long-term _3

Line of Credit and Long-term Debt - Schedule of Debt (Detail) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Term Loan	$ 43,253	$ 48,058
Term Loan (FCC Loan) [Member]
Debt Instrument [Line Items]
Term Loan	21,312	22,788
Term Loan One [Member] | Pure Sunfarms [Member]
Debt Instrument [Line Items]
Term Loan	7,028	8,298
Term Loan Two [Member] | Pure Sunfarms [Member]
Debt Instrument [Line Items]
Term Loan	11,560	13,201
BDC Facility [Member] | Pure Sunfarms [Member]
Debt Instrument [Line Items]
Term Loan	$ 3,353	$ 3,771

Line of Credit and Long-term _4

Line of Credit and Long-term Debt - Schedule of Debt (Parenthetical) (Detail) - 9 months ended Sep. 30, 2024 $ in Millions, $ in Millions	USD ($)	CAD ($)
Term Loan (FCC Loan) [Member]
Debt Instrument [Line Items]
Debt instrument, periodic principal payment	$ 164
Debt instrument, interest rate during period	8.81%	8.81%
Debt instrument maturity date	May 03, 2027	May 03, 2027
Term Loan One [Member] | Pure Sunfarms [Member]
Debt Instrument [Line Items]
Debt instrument, periodic principal payment		$ 19
Debt instrument, interest rate during period	8.45%	8.45%
Debt instrument maturity date	Feb. 07, 2026	Feb. 07, 2026
Debt Instrument Quarterly Payments Interest Rate	2.50%	2.50%
Term Loan Two [Member] | Pure Sunfarms [Member]
Debt Instrument [Line Items]
Debt instrument, periodic principal payment		$ 25
Debt instrument, interest rate during period	8.45%	8.45%
Debt instrument maturity date	Feb. 07, 2026	Feb. 07, 2026
Debt Instrument Quarterly Payments Interest Rate	2.50%	2.50%
BDC Facility [Member] | Pure Sunfarms [Member]
Debt Instrument [Line Items]
Debt instrument, periodic principal payment		$ 52
Debt instrument, interest rate during period	10.20%	10.20%
Debt instrument maturity date	Dec. 31, 2031	Dec. 31, 2031

Line of Credit and Long-term _5

Line of Credit and Long-term Debt - Additional Information (Detail) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Disclosure Of Borrowings [Line Items]
Line of credit	$ 4,000	$ 4,000
Weighted average interest rate	9.21%	9.44%
Accounts Payable and Accrued Liabilities [Member]
Disclosure Of Borrowings [Line Items]
Accrued interest payable	$ 405	$ 390
Non-Revolving Variable Rate Term Loan 2021 [Member] | FCC Loan [Member]
Disclosure Of Borrowings [Line Items]
Securities pledged as collateral	74,942	117,293
Revolving Operating Loan [Member]
Disclosure Of Borrowings [Line Items]
Amounts drawn on facility	4,000	4,000
Securities pledged as collateral	23,233	28,034
Revolving Operating Loan [Member] | Pure Sunfarms [Member]
Disclosure Of Borrowings [Line Items]
Total outstanding amount	$ 0	$ 0

Line of Credit and Long-term _6

Line of Credit and Long-term Debt - Summary of Aggregate Annual Principal Maturities of Long-Term Debt (Detail) $ in Thousands	Sep. 30, 2024 USD ($)
Debt Disclosure [Abstract]
Remainder of 2024	$ 1,440
2025	5,759
2026	16,856
2027	17,348
2028	462
Thereafter	1,388
Total	$ 43,253

Related Party Transactions An_2

Related Party Transactions And Balances - Additional Information (Detail) $ in Thousands, $ in Thousands		3 Months Ended				9 Months Ended
	May 29, 2024 USD ($)	Sep. 30, 2024 CAD ($)	Sep. 30, 2024 USD ($)	Sep. 30, 2023 CAD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2024 CAD ($)	Sep. 30, 2024 USD ($)	Sep. 30, 2023 CAD ($)	Sep. 30, 2023 USD ($)
Rose Acquisition
Related Party Transaction [Line Items]
Additional percentage of voting interests acquired		80%	80%			80%	80%
Employees
Related Party Transaction [Line Items]
Salary and benefits to employee			$ 45		$ 42		$ 130		$ 103
Employees | Share Purchase Agreement | Rose Acquisition
Related Party Transaction [Line Items]
Additional percentage of voting interests acquired	10%
Business combination cash purchase price of acquisition	$ 3,016
Rose
Related Party Transaction [Line Items]
Salary and benefits to employee		$ 40		$ 80		$ 230		$ 172

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Income Tax Disclosure [Abstract]
(Provision for) recovery of income taxes	$ (94)	$ 1,664	$ (674)	$ (269)
Valuation allowance	48,742		48,742		$ 42,530
Total deferred tax assets	$ 1,201		$ 1,201

Segment and Geographic Inform_3

Segment and Geographic Information - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2024 Segment
Segment Reporting [Abstract]
Number of operating segments	4

Segment and Geographic Inform_4

Segment and Geographic Information - Summary of net sales by the countries and business (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Sales [Abstract]
Sales	$ 83,368	$ 69,510	$ 253,627	$ 211,378
Gross profit [Abstract]
Gross profit	15,708	14,621	40,469	38,420
Income (loss) before taxes [Abstract]
Income (loss) before taxes	2,108	767	(15,933)	253
Produce Business [Member]
Sales [Abstract]
Sales	42,770	35,712	125,883	114,125
Gross profit [Abstract]
Gross profit	3,481	1,492	2,627	(654)
Income (loss) before taxes [Abstract]
Income (loss) before taxes	403	(1,172)	(7,787)	(4,497)
Cannabis Canada Business [Member]
Sales [Abstract]
Sales	36,463	28,810	114,654	81,987
Gross profit [Abstract]
Gross profit	9,599	9,944	29,812	29,114
Income (loss) before taxes [Abstract]
Income (loss) before taxes	1,600	1,918	4,689	5,003
Cannabis United States Business [Member]
Sales [Abstract]
Sales	3,943	4,988	12,777	15,266
Gross profit [Abstract]
Gross profit	2,500	3,185	7,824	9,981
Income (loss) before taxes [Abstract]
Income (loss) before taxes	(192)	79	(13,173)	(125)
Energy Business [Member]
Sales [Abstract]
Sales	192		313
Gross profit [Abstract]
Gross profit	128		206	(21)
Income (loss) before taxes [Abstract]
Income (loss) before taxes	$ 297	$ (58)	$ 338	$ (128)

Segment and Geographic Inform_5

Segment and Geographic Information - Summary of reconciliation of the company's segment income (loss) before taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Segment Reporting [Abstract]
Segment operating income	$ 2,108	$ 767	$ (15,933)	$ 253
Other corporate expenses, net	(2,764)	(3,684)	(10,380)	(9,293)
Loss before taxes	$ (656)	$ (2,917)	$ (26,313)	$ (9,040)

Loss Per Share - Summary of Bas

Loss Per Share - Summary of Basic and Diluted Net Loss per Common Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Numerator:
Net loss attributable to Village Farms International, Inc. shareholders	$ (820)	$ (1,299)	$ (27,221)	$ (9,315)
Denominator:
Weighted average number of common shares - basic	111,917	110,239	111,045	108,214
Weighted average number of common shares - diluted	111,917	110,239	111,045	108,214
Antidilutive options and awards	6,692	6,509	6,692	6,509
Net loss per ordinary share:
Basic	$ (0.01)	$ (0.01)	$ (0.25)	$ (0.09)
Diluted	$ (0.01)	$ (0.01)	$ (0.25)	$ (0.09)

Shareholders' Equity and Shar_3

Shareholders' Equity and Share Based Compensation - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Sep. 03, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share based compensation expense	$ 875	$ 747	$ 3,476	$ 3,135
Director [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Granted shares					600,000

Shareholders' Equity and Shar_4

Shareholders' Equity and Share Based Compensation - Summary of Stock Option Activity (Detail) - Stock Option [Member] - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of Options, Beginning balance	6,946,576
Number of Options, Granted	170,000
Number of Options, Forfeited/expired	(424,167)
Number of Options, Ending balance	6,692,409	6,946,576
Number of Options, Exercisable	3,600,055
Weighted Average Exercise Price, Beginning balance	$ 3.5
Weighted Average Exercise Price, Granted	0.95
Weighted Average Exercise Price, Forfeited/expired	3.43
Weighted Average Exercise Price, Ending balance	3.43	$ 3.5
Weighted Average Exercise Price, Exercisable	$ 5.24
Weighted Average Remaining Contractual Term (years)	7 years 1 month 2 days	7 years 6 months 14 days
Weighted Average Remaining Contractual Term (years), Granted	6 years 2 months 15 days
Weighted Average Remaining Contractual Term (years), Exercisable	5 years 11 months 19 days
Aggregate Intrinsic Value	$ 294	$ 83
Aggregate Intrinsic Value, Granted	5
Aggregate Intrinsic Value, Excercisable	$ 57

Shareholders' Equity and Shar_5

Shareholders' Equity and Share Based Compensation - Summary of Restricted Shares Activity (Detail) - Restricted Stock Grants [Member]	9 Months Ended
	Sep. 30, 2024 $ / shares shares
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]
Number of Restricted Stock Grants, Granted | shares	1,785,144
Number of Restricted Stock Grants, Vested and Issued | shares	(1,479,024)
Number of Restricted Stock Grants, Ending balance | shares	306,120
Weighted Average Grant Date Fair Value, Granted | $ / shares	$ 1.2
Weighted Average Grant Date Fair Value, Vested and Issued | $ / shares	1.25
Weighted Average Grant Date Fair Value, Ending balance | $ / shares	$ 0.98

Changes in Non Cash Working C_3

Changes in Non Cash Working Capital Items - Summary of Changes in Non Cash Working Capital Items and Supplemental Cash Flow Information (Detail) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]
Trade receivables	$ (625)	$ (475)
Inventories	16,000	(5,284)
Other receivables	(65)	9
Prepaid expenses and deposits	1,774	(845)
Trade payables	(3,231)	(3,624)
Accrued liabilities	(3,136)	5,383
Lease liabilities	(1,617)	(1,574)
Other assets, net of other liabilities	(3,798)	4,219
Total	$ 5,302	$ (2,191)

Changes in Non Cash Working C_4

Changes in Non Cash Working Capital Items and Supplemental Cash Flow Information - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Supplemental Cash Flow Information [Abstract]
Income taxes paid	$ 0	$ 0	$ 0	$ 0
Interest expense paid	$ 955	$ 1,008	$ 3,128	$ 3,645